K. -M. Kaukonen, R. Linko, H. Herwald, L. Lindbom, E. Ruokonen, T

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J. R. Masclans, M. Pérez, J. Almirall, L. Lorente, A. Marqués, L

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

J. Gonçalves-Pereira, A. Martins, P. Póvoa

Gut bacterial microbiota and obesity

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

C-reactive protein as a marker of infection in critically ill patients

Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of.

An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford,

Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era T.I. Pedersen, M. Howitz, C. Østergaard Clinical.

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

E. Bronska, J. Kalmusova, O. Dzupova, V. Maresova, P. Kriz, J. Benes

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

B. Beović, S. Kreft, J. Osredkar, D. Keše, B. Bonač-Tuma

Clinical and microbiological outcome in septic patients with extremely low 25- hydroxyvitamin D levels at initiation of critical care G. De Pascale, M.S.

R. Cantón Clinical Microbiology and Infection

Public health significance of invasive mosquitoes in Europe

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus P.-R. Hsueh, L.-M. Huang, P.-J.

J. Rello, E. Afonso, T. Lisboa, M. Ricart, B. Balsera, A. Rovira, J

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic A.S.

Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. H. Wisplinghoff, H. Seifert,

J. Gonçalves-Pereira, A. Martins, P. Póvoa

C. Costa, F. Sidoti, A. Saldan, F. Sinesi, C. Balloco, S. Simeone, M

Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D.

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing L. Bissonnette, M.G. Bergeron Clinical.

Vector control: a cornerstone in the malaria elimination campaign

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia F.M. Brunkhorst, B. Al-Nawas, F. Krummenauer,

Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood-a prospective quasi-randomized controlled trial H. Peltola,

G. Höffken Clinical Microbiology and Infection

Sepsis and neutropenia induced by clozapine

Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis J.-W. Yang, L.-C. Fan, X.-Y. Miao, B.

M. Or, M. Samish, T. Waner, S. Harrus

Human infection with H9N2 avian influenza in northern China

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: a population-based cohort study K.O. Gradel, R.W. Thomsen, S.

Recent developments in staphylococcal scalded skin syndrome

F. Blasi, P. Palange, G. Rohde, T. Severin, G. Cornaglia, R. Finch

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Current experience in treating invasive zygomycosis with posaconazole

Reducing antibiotic use in influenza: challenges and rewards

A.P. Underwood, J. Green Clinical Microbiology and Infection

Fibronectin concentrations in catheter sepsis

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Molecular identification of Acinetobacter sp

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae I. Gustafsson, O. Cars Clinical Microbiology.

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia U. Hohenthal, S. Hurme, H. Helenius,

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study)

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Heparin-binding protein (HBP) in critically ill patients with influenza A (H1N1) infection K.-M. Kaukonen, R. Linko, H. Herwald, L. Lindbom, E. Ruokonen, T. Ala-Kokko, V. Pettilä Clinical Microbiology and Infection Volume 19, Issue 12, Pages 1122-1128 (December 2013) DOI: 10.1111/1469-0691.12156 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Heparin binding protein (HBP) concentrations (ng/mL) at admission correlated with WBC (white blood cell) count (×109) at admission (rho = 0.444, p <0.01) but not with CRP (C-reactive protein, g/L) at admission (rho = 0.266, p 0.179). Clinical Microbiology and Infection 2013 19, 1122-1128DOI: (10.1111/1469-0691.12156) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Upper panel: HBP concentrations (ng/mL) in patients with and without invasive mechanical ventilation at baseline (p 0.088) and day 2 (p <0.01). Lower panel: HBP concentrations in tertiles of patients divided according to admission PF ratio at baseline and day 2 (p ns). Clinical Microbiology and Infection 2013 19, 1122-1128DOI: (10.1111/1469-0691.12156) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 3 Heparin binding protein concentrations (ng/mL) at baseline and day 2 in patients with and without corticosteroid therapy (p not significant at baseline; p <0.05 at day 2) and with and without severe sepsis or septic shock during their ICU stay (p not significant at baseline and day 2). Clinical Microbiology and Infection 2013 19, 1122-1128DOI: (10.1111/1469-0691.12156) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions